Summary

US Blood Glucose Monitoring Devices Market is valued at approximately USD 3.59 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.66% over the forecast period 2024-2032. Blood glucose monitoring devices measure the amount of glucose (sugar) in the blood. There are two types of glucose monitoring devices: blood sugar meters and continuous glucose monitors. People with diabetes use blood glucose monitoring devices to monitor and regulate their blood sugar levels. People with diabetes can keep their blood sugar levels in a safe range by monitoring them and modifying their diet, activity, or medication accordingly. Also, the growing trend towards home healthcare in the US significantly supports the growth of the Blood Glucose Monitoring Devices Market. Home healthcare allows individuals to manage their health conditions from the comfort of their homes. This convenience encourages more frequent monitoring of blood glucose levels, as individuals can perform tests at their convenience without the need to visit a healthcare facility.

In addition, increasing awareness among patients regarding the importance of regular blood glucose monitoring for diabetes management, coupled with higher healthcare expenditure, drives the demand for blood glucose monitoring devices. Also, continuous technological advancements in blood glucose monitoring devices have improved accuracy, convenience, and ease of use. Innovations like continuous glucose monitoring (CGM) systems, wearable devices, and smartphone integration have enhanced patient compliance and monitoring capabilities. Additionally, government initiatives aimed at promoting diabetes management and prevention, along with favorable reimbursement policies for diabetes monitoring devices, encourage the adoption of these devices among patients. However, the high cost of devices and fluctuating raw material prices is expected to hinder the US Blood Glucose Monitoring Devices Market growth during the forecast period 2024-2032.


Major market players included in this report are:

Dexcom, Inc.
ForaCare, Inc.
Trividia Health, Inc.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Product
Self-monitoring Devices
Continuous Blood Glucose Monitoring Devices

By End-use
Hospitals
Home Care
Diagnostic Centers

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Blood Glucose Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Blood Glucose Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Product
2.2.2. By End-use
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Blood Glucose Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Blood Glucose Monitoring Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Blood Glucose Monitoring Devices Market Size & Forecasts by Product 2022-2032
5.1. Self-monitoring Devices
5.2. Continuous Blood Glucose Monitoring Devices
Chapter 6. US Blood Glucose Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Hospitals
6.2. Home Care
6.3. Diagnostic Centers
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Dexcom, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. ForaCare, Inc.
7.3.3. Trividia Health, Inc.
7.3.4. Company 4
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes